Los Angeles Capital Management & Equity Research Inc. decreased its position in HCP, Inc. (NYSE:HCP) by 56.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,693 shares of the real estate investment trust’s stock after selling 41,530 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in HCP were worth $834,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. Mount Yale Investment Advisors LLC purchased a new stake in shares of HCP in the second quarter valued at about $104,000. Piedmont Investment Advisors LLC purchased a new stake in shares of HCP in the second quarter valued at about $142,000. Peoples Financial Services CORP. boosted its holdings in shares of HCP by 87.7% in the third quarter. Peoples Financial Services CORP. now owns 6,100 shares of the real estate investment trust’s stock valued at $161,000 after acquiring an additional 2,850 shares in the last quarter. Lourd Capital LLC purchased a new stake in shares of HCP in the third quarter valued at about $211,000. Finally, First Hawaiian Bank purchased a new stake in shares of HCP in the third quarter valued at about $215,000. 89.32% of the stock is currently owned by institutional investors and hedge funds.
Several analysts have recently weighed in on the stock. ValuEngine raised shares of HCP from a “hold” rating to a “buy” rating in a report on Monday, November 12th. Zacks Investment Research reaffirmed a “sell” rating on shares of HCP in a report on Tuesday, November 13th. Royal Bank of Canada raised shares of HCP from a “sector perform” rating to an “outperform” rating in a report on Friday, November 2nd. Cantor Fitzgerald boosted their price objective on shares of HCP from $29.00 to $30.00 and gave the stock an “overweight” rating in a report on Thursday, November 1st. Finally, BMO Capital Markets reissued a “hold” rating and set a $27.00 price objective on shares of HCP in a report on Wednesday, October 31st. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $26.75.
HCP (NYSE:HCP) last released its quarterly earnings data on Wednesday, October 31st. The real estate investment trust reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.10. The firm had revenue of $456.00 million for the quarter, compared to the consensus estimate of $456.59 million. HCP had a net margin of 9.16% and a return on equity of 3.06%. The firm’s revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.48 earnings per share. On average, equities analysts predict that HCP, Inc. will post 1.82 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 20th. Investors of record on Monday, November 5th were issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a yield of 5.15%. The ex-dividend date of this dividend was Friday, November 2nd. HCP’s dividend payout ratio is currently 75.90%.
COPYRIGHT VIOLATION WARNING: This news story was first published by WKRB News and is the property of of WKRB News. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.wkrb13.com/2018/11/25/los-angeles-capital-management-equity-research-inc-has-834000-stake-in-hcp-inc-hcp.html.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
See Also: How to calculate compound interest
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.